Lv1
20 积分 2024-07-29 加入
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages
17小时前
已完结
The cGAS-STING pathway and cancer
8个月前
已完结
Dendritic cells as orchestrators of anticancer immunity and immunotherapy
8个月前
已完结
Hepatocellular carcinoma
1年前
已完结
皖公网安备34019202002308
